Elevation Oncology, Inc.
Net BuyingELEV·US·🇺🇸 US
71%buys·29%sales
239 transactions$95.0MTotal buys·17 buys
$14.5MTotal sells·7 sells
3030 insiders
Last: Jul 23, 2025
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Jul 23, 25 | Furlong Tammy | Disposition | - | |
| Jul 23, 25 | Furlong Tammy | Disposition | - | |
| Jul 23, 25 | Furlong Tammy | Disposition | - | |
| Jul 23, 25 | Furlong Tammy | Disposition | - | |
| Jul 23, 25 | Furlong Tammy | Disposition | - | |
| Jul 23, 25 | Furlong Tammy | Disposition | - | |
| Jul 23, 25 | Furlong Tammy | Disposition | - | |
| Jul 23, 25 | Furlong Tammy | Disposition | - | |
| Jul 23, 25 | Carruthers R Michael | Disposition | - | |
| Jul 23, 25 | Carruthers R Michael | Disposition | - |
Elevation Oncology, Inc. (ELEV) has recorded 239 insider transactions from 30 insiders. Total insider buying volume stands at $95.0M, while total selling volume is $14.5M. Overall insider sentiment is bullish (71% purchases).
Elevation Oncology, Inc. (ELEV) has recorded 239 insider operations, including 17 open-market purchases ($95.0M), 7 sales ($14.5M) and 215 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bullish (71% purchases).
Insider activity at Elevation Oncology, Inc. is sustained, with operations recorded in 9 of the last 12 months — a sign of regular regulatory filings.
Among the most active insiders are Ferra Joseph J Jr (CEO), Leland Shawn (CEO) & Furlong Tammy (CFO), with respectively 50, 1, 35 transactions.
Across all 239 recorded transactions, the breakdown by type is: exercise (93, 39%), grant (68, 28%), disposition (31, 13%), tax (21, 9%), buys (17, 7%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Elevation Oncology, Inc. has recorded 239 insider operations in total, including 17 open-market purchases ($95.0M), 7 sales ($14.5M) and 215 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on July 23, 2025.
Insiders at Elevation Oncology, Inc. are currently net buyers, with 71% purchases and 29% sales across all reported transactions. Total buy volume is $95.0M versus $14.5M in sales, indicating a bullish insider sentiment.
InsiderLens tracks 30 insiders at Elevation Oncology, Inc. (ELEV). Ferra Joseph J Jr (CEO, 50 tx), Leland Shawn (CEO, 1 tx), Furlong Tammy (CFO, 35 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for ELEV is bullish, based on a 71% buy ratio across 24 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Elevation Oncology, Inc. comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.